Document:

Exhibit 10.22

AMENDMENT TO

VANTAGEMED CORPORATION

SERIES          WARRANT TO PURCHASE
SHARES

OF COMMON STOCK, PAR VALUE $0.001 PER SHARE

February 16,
2007

This Amendment
(this “Amendment”) to VantageMed Corporation Series     
Warrants to Purchase Shares of Common Stock, Par Value $0.001 per Share (the “Series     
Warrants”) shall, pursuant to Section 21 of the Series     Warrants,
be effective as to the holders of Series      Warrants
upon the execution of this Amendment by VantageMed Corporation (the “Company”)
and the undersigned holders of such Series     
Warrants representing the Majority Holders. Capitalized terms not otherwise
defined herein shall have the meaning ascribed to them in the Series     
Warrants.

1.     Except as
otherwise provided herein, the terms of the Series     
Warrants will remain in full force and effect.

2.     Effective
as of the effective date hereof, each Series     
Warrant shall be amended by adding to Section 8 thereto a new subsection (i) as
follows:

(i)    Notwithstanding
anything to the contrary herein, in the event that the Company shall agree to
enter into a merger transaction with another corporation in a transaction in
which all of the holders of outstanding shares of Common Stock will exchange
their shares solely for the right to receive cash (a “Cash Merger”), the
Company will provide to the holders of Series     
Warrants at least twenty (20) days written notice of the proposed effective
date of such Cash Merger (the “Merger Notice”), which notice shall include in
reasonable detail the terms of such merger. To the extent any portion of this
Warrant remains unexercised on the effective time of such Cash Merger (the “Effective
Time”), this Warrant will terminate and no longer be exercisable. Any exercise
of Series      Warrants in the manner provided herein
during the period after the date of the Merger Notice but prior to the
Effective Time may be conditioned on the occurrence of the Effective Time, and
in the event the Cash Merger is terminated prior to the Effective Time, such
exercises may be rescinded by the holders without obligation. In the event of
any such termination, any cash held by the Company pending the Effective Time
representing an exercise amount will be returned to the holder without
deduction or set-off.

3.     The
undersigned represents that it is the record Holder of Series     
Warrants to purchase the number of shares of Common Stock listed next to the
undersigned’s name below.

4      This
Amendment may be executed in one or more counterparts, including by facsimile,
all of which shall be considered one and the same agreement and shall become
effective when one or more counterparts have been signed by each of the parties
and delivered to the other party.

5      This
Amendment shall be governed by and construed in accordance with the laws of the
State of New York, regardless of the laws that might otherwise govern under
applicable principles of conflicts of laws thereof. Each of the parties hereto
irrevocably consents to the exclusive jurisdiction and venue of the state or federal
courts located in New York City in connection with any matter based upon or
arising out of this Amendment or the matters contemplated herein, agrees that
process may be served upon them in any manner authorized by the laws of the
State of New York for such persons.

[Signature
Page Follows]

 1
 

IN
WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be
signed individually or by its respective duly authorized officer as of the date
first written above.

	
  

  	
  VANTAGEMED
  CORPORATION

  CORPORATION

  
	
   

  	
  By:

  	
   

  
	
   

  	
  Name:

  	
   

  
	
   

  	
  Title:

  	
   

  
	
   

  	
  WARRANTHOLDER:

  
	
   

  	
   

  
	
   

  	
  (Print
  Warrantholder Name)

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  (Signature)

  
	
   

  	
  Name:

  	
   

  
	
   

  	
   

  	
  (Print Name)

  
	
   

  	
  Title:

  	
   

  
	
   

  	
  Series     
  Warrants beneficially owned:

  
	
   

  	
   

  

 

 2Exhibit
10.4

Dendrite
International, Inc.

Compensation Committee

ESPP - Treatment of Plan Participants in Merger Agreement

Resolutions

March 1, 2007

The following resolution was unanimously adopted by the Compensation
Committee of the Board of Directors of Dendrite International, Inc. (the “Company”)
at a meeting of the Committee held on March 1, 2007.

RESOLVED, that given that there are and were insufficient shares of
Company common stock (“Shares”) available under the Company’s Employee Stock
Purchase Plan (“ESPP”) to deliver to the participants the Shares that would
have otherwise been purchased under the ESPP during the offering periods
relating to the Company’s 2006 fourth quarter (“4Q Offering Period”) and the
2007 first quarter (“1Q Offering Period”) the Committee considers it fair,
equitable, reasonable and appropriate for the Company to make certain cash
payments to the ESPP participants; and

RESOLVED, that the Company is hereby fully authorized to commit to pay
(and to pay), at the closing of the Merger, to each participant in the ESPP who
had elected to participate in and to purchase shares of the Company’s common
stock under the ESPP in the offering period (“4Q Offering Period”) relating to
the Company’s 2006 fourth quarter, (i) an amount equal to the amount actually
deferred by each such participant in the 4Q Offering Period which has not been
converted into shares pursuant to the ESPP, with interest at a rate reasonably
determined by the Company, plus (ii) an amount equal to: (x) the Per Share Merger
Consideration less (y) the discounted purchase price applicable under
the ESPP for the 4Q Offering Period, times (z) the theoretical number of
shares which the participant would have acquired under the ESPP in the 4Q
Offering Period using the cash actually deferred by the participant for the 4Q
Offering Period which has not been converted into shares pursuant to the ESPP;
and

RESOLVED, that the Company is hereby fully authorized to commit to pay
(and to pay), at the closing of the Merger, to each participant in the ESPP who
had elected to participate in and to purchase shares under the ESPP in the
offering period (“1Q Offering Period”) relating to the Company’s 2007 first
quarter, (i) an amount equal to the amount actually deferred by each such
participant in the 1Q Offering Period, with interest at a rate reasonably
determined by the Company, plus (ii) an amount equal to: (x) the Per Share
Merger Consideration less (y) the discounted purchase price applicable
under the ESPP for the 1Q Offering Period, times (z) the theoretical
number of shares which the participant would have acquired under the ESPP in
the 1Q Offering Period based on the amount actually deferred by the participant
during the 1Q Offering Period; and

RESOLVED, that in the event the proposed Merger is not consummated, the
Company is hereby fully authorized to commit to pay (and to pay) the amounts
contemplated in the prior two resolutions as though the Per Share Merger
Consideration were equal to the fair market value of the Company’s common stock
used to determine the discounted purchase price applicable under the ESPP for
the 4Q Offering Period or the 1Q Offering Period, as applicable; and

RESOLVED, that the Company will not accept deferrals or participation
for any offering period following the 1Q Offering Period; and

RESOLVED,
that the officers of the Company be and hereby are authorized (with full power
of delegation), empowered and directed, for, on behalf of, and in the name of
the Company, to take all further actions necessary or desirable in order to
execute and implement the foregoing resolutions, and to incur such expenses as
are in their judgment necessary or appropriate to carry out the foregoing
resolutions, with the taking of any and all such actions and the performance of
any and all such things in connection therewith conclusively establishing each
such officer’s authority therefore from the Company. 

 

	
  /s/ Bernard M. Goldsmith 

  	
   

  	
  /s/ Peter W. Ladell 

  
	
  Bernard M.
  Goldsmith

  	
   

  	
  Peter W. Ladell

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  /s/ Edward J.
  Kfoury 

  	
   

  	
   

  
	
  Edward J. KfouryExhibit
10.6

AMENDMENT

THIS
AMENDMENT is made as of March 1, 2007 and amends the
Employment Agreement dated as of May 16, 2006 (the “Employment Agreement”)
between DENDRITE INTERNATIONAL, INC. (“Dendrite”)
and JOHN E. BAILYE (“Employee”).  Unless defined in this Amendment, capitalized
terms used in this Amendment will have the meaning set forth in the Employment
Agreement.

WHEREAS, the Company and the Employee are parties to
the Employment Agreement and wish to amend the Employment Agreement; and

WHEREAS, at the time at which the Compensation
Committee of the Board approved and the Company entered into the Employment
Agreement it was the full intent and agreement of the Compensation Committee
and of the Company, as well as the intent and agreement of the Employee, that
full IRC Section 280G/4999 excise tax gross-up protection was being afforded to
the Employee, and in order to clarify and avoid any claim of ambiguity, the
Compensation Committee has approved and authorized the deletion of the phrase “and
(B) such Excise Taxes which become payable by you equal or exceed 20% of the
Total Payments” from the first sentence of Section 4(f) of the Employment
Agreement, which phrase had been inadvertently included in the above sentence
in Section 4(f) of the Employment Agreement.

NOW, THEREFORE, in consideration of the premises and
mutual covenants contained in this Amendment, the Company and the Employee
agree as follows:

1.             The
first paragraph of Section 4(f) of the Employment Agreement is
restated in its entirety to provide as follows:

“(f)          Notwithstanding any
other provision of this Agreement or any other agreement between you and
Dendrite, if you become entitled to one or more payments (with a “payment”
including, without limitation, the vesting of an option or other non-cash
benefit or property) pursuant to any plan, agreement or arrangement of Dendrite
(together, “‘Total Payments”) which are or become subject to the tax imposed by
Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”)(or
any similar tax that may be imposed) (the “Excise Tax”), Dendrite will pay you
an additional amount (“Gross-Up Payment”) in an amount such that the after tax
payment of all taxes (including without limitation all income and employment
tax and Excise Tax and treating as a tax the disallowance of any deduction by
virtue of the inclusion of the Gross-Up Payment in your adjusted Gross Income),
and interest and penalties with respect to such taxes, imposed upon the
Gross-Up Payment, you retain an amount of the Gross-Up Payment equal to the
Excise Taxes. The determination of whether any such Gross-Up Payment is due you
and the amount of such payment, if any, shall be made at Dendrite’s expense by
a nationally recognized accounting firm mutually acceptable to you and Dendrite
and such determination of such firm shall be binding on both you and Dendrite.”

2.             Except
as expressly modified by this Amendment, all of the terms and conditions of the
Employment Agreement shall remain in full force and effect.

IN WITNESS WHEREOF, the parties
have signed this Amendment as of the first date written above.

DENDRITE
INTERNATIONAL, INC.

	
  

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ Christine
  Pellizzari

  
	
   

  	
   

  	
  Name:

  	
  Christine Pellizzari

  
	
   

  	
   

  	
  Title:

  	
  Senior Vice President, General Counsel and 

  Secretary

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ John E.
  Bailye

  
	
   

  	
   

  	
  John E. Bailye

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]